Showing results (571-580 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|April 27, 2016
Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumabFrancisco Aya, Aranzazu Fernández-Martínez, Lydia Gaba, et al.Immunotherapy|February 12, 2016
Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinomaTai Hato, Andrew X Zhu, Dan G DudaImmunotherapy|August 28, 2015
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectivesLidia Giraudo, Loretta Gammaitoni, Michela Cangemi, et al.Immunotherapy|August 14, 2015
New developments in immunotherapies for food allergyKrishan Dilip Chhiba, Anne Marie Singh, Paul J BryceImmunotherapy|May 24, 2019
Immunometabolism: an overview and therapeutic prospects in autoimmune diseasesChrysoula Stathopoulou, Dimitra Nikoleri, George BertsiasImmunotherapy|August 4, 2018
Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve accessPedro Aguiar, Auro Del Giglio, Luke Alastair Perry, et al.Immunotherapy|August 4, 2018
Primary malignant melanoma of the esophagus, treated with immunotherapy: a case reportPauline Rochefort, Juliette Roussel, Arnaud de la Fouchardière, et al.Immunotherapy|August 4, 2018
Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapyTaylor R Cushman, Mauricio S Caetano, James W Welsh, et al.Immunotherapy|August 4, 2018
Characterization of monocyte-derived dendritic cells used in immunotherapy for HIV-1-infected individualsLaís Teodoro da Silva, Wanessa Cardoso da Silva, Alexandre de Almeida, et al.Immunotherapy|September 22, 2018
Long-term safety of α-1 antitrypsin therapy in children and adolescents with Type 1 diabetesAvivit Brener, Yael Lebenthal, Hagar Interator, et al.Pageof 190